Zhifei Biological
SZSE · 300122
Market Cap$29.8B
Revenue$8.8B
Employees6292
Listed OnSZSE
Ticker300122
CEO / ExecMr. Lingfeng Jiang
HeadquartersChongqing
MarketMainland China
Websitewww.zhifeishengwu.com
Overview
Chongqing Zhifei Biological Products Co., Ltd., a biopharmaceutical company, engages in the research and development, production, sale, and distribution of vaccine and biological products in China. The company offers recombinant COVID-19 vaccine; recombinant mycobacterium tuberculosis fusion protein products; group A and C meningococcal polysaccharide vaccine; ACYW135 meningococcal polysaccharide vaccine; Haemophilus Influenza type B conjugate vaccine; mycobacterium injection under the Vaccae br
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.